<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药时代 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-04T07:35:08+08:00</updated>
  <subtitle>欢迎您走进药时代！这是一个千载难逢的医药研发新时代！我们分享最新的有价值的行业资讯，讲述医药背后感人的故事，举办形式多样、内容丰富的线上线下活动，与朋友们一起学习成长，将新药研发事业进行到底，让新药带给世界更多更大的健康</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020年中国创新药跨境license in交易哪家强？TOP18榜单出炉！</title>
    <updated>2021-01-04T07:08:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/SlMjEueZqpSzXnLbkD7Qjg</id>
    <link href="https://mp.weixin.qq.com/s/SlMjEueZqpSzXnLbkD7Qjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药在韩国提交ATG-010（Selinexor）的新药上市申请，用于治疗复发难治性多发性骨髓瘤及弥漫性大B细胞淋巴瘤</title>
    <updated>2021-01-04T07:08:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/WrbBSV4MfjdGMnKH_qOlKw</id>
    <link href="https://mp.weixin.qq.com/s/WrbBSV4MfjdGMnKH_qOlKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再极医药完成近2亿元人民币的C轮融资，优选资本领投</title>
    <updated>2021-01-04T07:08:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/qrl5C_omqMKu7DATMDWV7A</id>
    <link href="https://mp.weixin.qq.com/s/qrl5C_omqMKu7DATMDWV7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“中国好声音” | 第39届摩根大通医疗健康年会中国参展企业</title>
    <updated>2021-01-04T07:08:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/SqJ5g49LRYFGyZyijy1zRg</id>
    <link href="https://mp.weixin.qq.com/s/SqJ5g49LRYFGyZyijy1zRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物递送系统绕不开的话题——纳米颗粒</title>
    <updated>2021-01-04T07:08:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/Ar2Y9AM2lwqgakvKJlwWXA</id>
    <link href="https://mp.weixin.qq.com/s/Ar2Y9AM2lwqgakvKJlwWXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>继FDA之后，给国家药监局（NMPA）的一个小小的建议</title>
    <updated>2021-01-03T07:48:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/xqLeyCYTxCcawJ7PsSccqA</id>
    <link href="https://mp.weixin.qq.com/s/xqLeyCYTxCcawJ7PsSccqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年，这50篇文章受到关注</title>
    <updated>2021-01-03T07:48:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/FqqViF3-Kz8vQm7I-R_bvQ</id>
    <link href="https://mp.weixin.qq.com/s/FqqViF3-Kz8vQm7I-R_bvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>邀请函 | “伙力全开”——新药创始人俱乐部2021新春聚会</title>
    <updated>2021-01-03T07:48:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/GZr-k7KuKohoiZozmf8tvQ</id>
    <link href="https://mp.weixin.qq.com/s/GZr-k7KuKohoiZozmf8tvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>73名！中国科学院2021年院士增选启动</title>
    <updated>2021-01-03T07:48:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/oL4zib_VzikzN5dSpjU-kA</id>
    <link href="https://mp.weixin.qq.com/s/oL4zib_VzikzN5dSpjU-kA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>英国重启方舱医院！变异毒株能在各年龄段中快速传播 伦敦3家医院ICU病房“满员”</title>
    <updated>2021-01-03T07:48:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/3le7quj9d03VXa3g2LWV9Q</id>
    <link href="https://mp.weixin.qq.com/s/3le7quj9d03VXa3g2LWV9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿尔茨海默病药物开发作用机制盘点</title>
    <updated>2021-01-03T07:48:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/65f4eyc210nkzvMyBGUtVQ</id>
    <link href="https://mp.weixin.qq.com/s/65f4eyc210nkzvMyBGUtVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点NMPA批准的国产原创小分子激酶抑制剂</title>
    <updated>2021-01-03T07:48:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/Wq7j15uW7nLM_-Qq-HKBPg</id>
    <link href="https://mp.weixin.qq.com/s/Wq7j15uW7nLM_-Qq-HKBPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>EGFR三代靶向药物有哪些？未来靶向治疗思路是什么？</title>
    <updated>2021-01-03T07:48:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/kc93ZzkL2nvyj937U2zV0w</id>
    <link href="https://mp.weixin.qq.com/s/kc93ZzkL2nvyj937U2zV0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>谢雨礼博士 | 生物医药2021：把握创新转型的大势</title>
    <updated>2021-01-02T17:49:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/-Xj79LfxRgR--8sDGIYR5Q</id>
    <link href="https://mp.weixin.qq.com/s/-Xj79LfxRgR--8sDGIYR5Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准的62个小分子激酶抑制剂清单</title>
    <updated>2021-01-02T17:49:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/F95o3nUIvkyzQF6QK3dD-w</id>
    <link href="https://mp.weixin.qq.com/s/F95o3nUIvkyzQF6QK3dD-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>十年深耕，20 篇高水平论文，施一公团队Cell再解阿尔兹海默症重要蛋白结构</title>
    <updated>2021-01-02T17:49:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/hR8f_74j3WvicwLJioW_Aw</id>
    <link href="https://mp.weixin.qq.com/s/hR8f_74j3WvicwLJioW_Aw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东风西风齐登场，新冠疫苗哪家强？</title>
    <updated>2021-01-02T17:49:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/lrGGZ5MUE5HZgaiWvpl9EA</id>
    <link href="https://mp.weixin.qq.com/s/lrGGZ5MUE5HZgaiWvpl9EA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Me-too：First-in-class，想成药，咱们可太难了</title>
    <updated>2021-01-02T17:49:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/C0HFVhaBU3CNXaysx2SrYQ</id>
    <link href="https://mp.weixin.qq.com/s/C0HFVhaBU3CNXaysx2SrYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>来自CDE的新年“礼物”！~  CDE一次性发布近20个重要指导原则！</title>
    <updated>2021-01-01T00:30:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/xm6cyWE541mPBkxYJcXoiA</id>
    <link href="https://mp.weixin.qq.com/s/xm6cyWE541mPBkxYJcXoiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年，我们的​脚下依旧是前线！——重温华为短片，迎接期盼已久的新年！</title>
    <updated>2021-01-01T00:30:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/0KT2NG6VAfn5kuSZ9sEe2A</id>
    <link href="https://mp.weixin.qq.com/s/0KT2NG6VAfn5kuSZ9sEe2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>